Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
T細胞受容体α遺伝子を開裂するLAGLIDADGホーミングエンドヌクレアーゼおよびその用途
Document Type and Number:
Japanese Patent JP6450371
Kind Code:
B2
Abstract:
Disclosed herein are compositions for inactivating the human TCR-alpha gene comprising engineered LAGLIDADG homing endonucleases (LHEs) and their derivatives, particularly derived from members of the \-Onul subfamily of LHEs. Polynucleotides encoding such endonucleases, vectors comprising said polynucleotides, cells comprising or having been treated with such endonucleases, and therapeutic compositions deriving therefore are also provided.

Inventors:
Astrakhan alexander
Jersey jordan
Application Number:
JP2016516173A
Publication Date:
January 09, 2019
Filing Date:
May 28, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CELLECTIS
International Classes:
C12N15/09; A61K35/12; A61K35/15; A61K35/17; A61K35/28; A61K48/00; A61P35/00; C07K19/00; C12N9/16; C12N15/90
Foreign References:
WO2011156430A2
WO2013009525A1
WO2012138927A2
WO2013068845A2
Other References:
Blood,2012年 6月14日,Vol.119, No.24,p.5697-5705
PROVASI Elena, et al.,TCR Gene Editing Results in Effective Immunotherapy of Leukemia without the Development of GvHD,Blood,2011年,Vol.118, No.21,p.667
Proceedings of The National Academy of Sciences,2011年 8月 1日,Vol.108, No.32,p.13077-13082
Nucleic Acids Research,2012年 6月 7日,Vol.40, No.16,p.7985-8000
Nucleic Acids Research,2011年 8月 3日,Vol.39, No.21,p.9283-9293
Genome,2012年 8月,Vol.55, No.8,p.553-569
Methods Mol Biol,2013年 1月12日,Vol.978,p.45-61
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto